NVS said it was suing rival LLY in U.S. federal court, accusing the U.S. drugmaker of false advertising in claiming its weight-loss Medicine

NVS said it was suing rival LLY in U.S. federal court, accusing the U.S. drugmaker of false advertising in claiming its weight-loss Medicines outperform Novo's drugs.